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Abstract
Background:
Ventriculostomy-associated infection (VAI) is a major concern to physicians. Limited studies have
looked at the outcomes of external ventricular drain (EVD) infection and predictors of unfavorable
outcomes. In this study, we assessed the outcomes of EVD infection and predictors of unfavorable
outcomes.
Methods:
This was a retrospective medical chart review, conducted at the Aga Khan University Hospital. All the
patients irrespective of age and gender, fulfilling the diagnostic criteria of VAI were included. Patients
with preexisting bacterial meningitis or ventriculitis were excluded from the study. Outcome
assessment was based on Glasgow outcome scale (GOS) at 1 and 3 months after procedure. Other
outcomes included 30-day mortality and total length of hospital stay.
Results:
We included 256 patients in the study. 66 patients (25.8%) developed VAI. EVD was the primary
procedure in 21 (31.8%) cases. Most patients, 24 (36.4%), had EVD as a secondary procedure for
tumor surgery. Median interval between EVD placement and diagnosis of infection was 3 days. Mean
length of stay in VAI patients was 31.85 ± 20.53 days. Seven patients required ICU care. Ten patients
(15.2%) expired during hospital stay or within 30 days of discharge and further four had GOS of 2 or 3.
A total of 52 patients had a favorable outcome after 6 months.
Conclusions:
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Rate of VAI in this cohort was high. VAI is associated with increased morbidity, mortality, and
prolonged hospital stay.
Keywords: External ventricular drain, infection, ventriculostomy
INTRODUCTION
External ventricular drain (EVD) placement is one of the most commonly performed neurosurgical
procedures.[6] Indications for EVD include acute hydrocephalus, intracranial pressure (ICP)
monitoring, posterior fossa surgeries, and for administration of intraventricular antibiotics.
Ventriculostomy-associated infection (VAI) is the major complication of this procedure.[4] Reported
rates of VAI vary from 3–19%.[12] Numerous studies have shown that VAI is associated with an
increase in overall morbidity, mortality, length of hospital, and intensive care unit (ICU) stay.[1,2,14]
Focus of the studies on VAI has been to determine its predictors and outline measures to minimize and
prevent it. Few studies have looked at the outcomes of EVD infection and predictors of unfavorable
outcomes. We decided to determine the impact of VAI on outcomes of these patients. The subject was
of interest to us as we observed high rates of VAI in our setup.
MATERIALS AND METHODS
This was a retrospective observational study, conducted at the Aga Khan University Hospital, Karachi
by Sections of Infectious disease and Neurosurgery. The Aga Khan University Hospital is a tertiary
care facility and a referral center for neurosurgery.
Inclusion and exclusion criteria
All the patients irrespective of age and gender, fulfilling the diagnostic criteria of VAI were included.
Patients with preexisting bacterial meningitis or ventriculitis were excluded from the study.
Operational definition
VAI was diagnosed if a patient has any three of the following within 2 months of EVD insertion:
Cerebrospinal fluid (CSF) positive cultures
CSF glucose <45 gm/dL
CSF white cell count >10/mm
CSF protein >45 mg/dL
Diagnosis of meningitis by infectious diseases consultant.
External ventricular drain insertion and management
At our center EVD is inserted in the main operating room by a senior resident or instructor under
supervision of a consultant. Common indications of the procedure include hydrocephalus due to,
intracranial hemorrhage (ICH) with intraventricular extension, tuberculosis meningitis (TBM),
subarachnoid hemorrhage (SAH). Other indications include posterior fossa surgeries. Most common
site of insertion is Kocher's point and the right side is preferred. For posterior fossa surgeries, EVD is
inserted through Keene's point. A BMI® EVD system is used for insertion and subsequent drainage
and pressure monitoring. A minimum of 5 cm subcutaneous tunneling of catheter is performed. CSF
cultures are routinely sent every 72 hours till the EVD is in place and whenever VAI is suspected
clinically. EVD tip and CSF culture are also sent at the time of removal of drain. Impermeable sterile
dressing is applied and changed on alternate days or whenever a stain is noticed.
Outcome measures
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Outcomes were based on Glasgow outcome scale (GOS) at 3 months, post-procedure. Score of 1–3 was
regarded as unfavorable outcome while score of 4–5 was grouped as favorable outcome. Other
outcomes included 30-day mortality and total length of hospital stay.
Data collection
Data were collected according to a self-designed form. Same investigator was assigned to collect the
data. Variables included age, gender, primary diagnosis, co-morbids, reason for EVD insertion, site and
length of EVD tunnel, number of days with EVD, components of diagnostic criteria, and intervention
done for VAI. Variables on outcomes were recorded as defined. We used medical records, Patient Care
Inquiry (PCI – hospital online database for patient laboratory and radiology reports). For incomplete
records, the patients/attendants were contacted through telephone. A formal introduction about the
study was given and informed consent was taken before obtaining any information.
Approval from the Departmental Review Committee (DRC) and the Ethical Review Committee (ERC)
was sought before commencement of the study. The data was handled by the principal investigator and
his team only, making sure that the patient's identity and confidentiality is preserved during all stages.
Data analysis
Data from the forms was entered into Microsoft Excel, checked for missing variables and screened to
remove duplicates. Then all data was entered via EpiData software version 3.1 and analyzed using
Statistical Package for Social Sciences (SPSS) version 21 (IBM SPSS Statistics). Continuous variables
with normal and non-normal distributions were represented as mean [standard deviation (SD)] and
median (interquartile range) respectively. Categorical data was represented as percentage and
proportions. We grouped the data according to the outcomes (favorable versus unfavorable). Means
were compared with the help of independent sample t-test while Chi-square test was used to compare
the categorical data.
Sample size
Sample size was calculated by considering the objectives of the study. We used Epi Info version 6 to
calculate the sample size. The sample size calculation was based on the assumption that the prevalence
of EVD infection was 16.9% per procedure. Therefore, taking the frequency of 17% with 95%
confidence level and with 5% (0.05) bound on error of estimation, a sample of 217 participants was
required.
To identify the factors associated with EVD infection the sample size for the most important factor
(mortality) was estimated. Poor outcome was present in 40% of the unexposed group. By considering
these figures together with 95% confidence interval, 80% power and relative risk of 1.39, the sample
size came out to be 320. Sample size accommodating the risk factors was larger than the prevalence, so
320 study participants were required to cover the study objectives.
RESULTS
A total of 369 patients underwent the EVD placement over the study period. Two hundred and fifty six
patients underwent the procedure in previously sterile CSF. Of the 256 patients, 66 (25.8%) developed
EVD infection per our definition. Mean age of patients with EVD infection was 37.92 ± 22.47 years.
Thirty-eight patients (57.6%) were male and 28 females (42.4%). In 63 patients, the diagnosis of VAI
was based on reports of CSF Detailed Report and Culture and Sensitivity while another three had
positive EVD tip culture as well. Frequency of organisms isolated on CSF culture shown in Table 1.
About 17 patients (15.8%) had concurrent infection elsewhere in the body as well. Twenty-one patients
had a GCS of 9 or less at the time of presentation.
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Table 1
Frequency of organisms isolated on cerebrospinal fluid (CSF) culture
EVD was the primary procedure in 21 (31.8%) cases. Most patients 24 (36.4%) had EVD as a
secondary procedure for tumor surgery. ICH was present in another 24 (36.4%). Other procedures were
done for CSF rhinorrhea and otorrhea, after traumatic brain injury (TBI), suspected TBM, for
hydrocephalus or with endoscopic third ventriculostomy (ETV). Median interval between EVD
placement and diagnosis of infection was 3 days with an interquartile range of 9.75 days. Twenty
patients had a history of EVD in the past.
Twenty-nine patients had definitive CSF diversion procedure. Twenty-three patients had a VP shunt
and six had long tunnel EVD. Mean length of stay was 31.85 ± 20.53 days. Seven patients required
ICU care. Ten patients (15.2%) expired during hospital stay or within 30 days of discharge and further
four had GOS of 2 or 3. Clinical characteristics of survivors and non-survivors are given in Table 2. A
total of 52 patients had a favorable outcome after 6 months, defined as GOS 4–5. Of 66 patients with
EVD infection 55 patients achieved CSF sterility.
Table 2
Clinical characteristics of survivors and nonsurvivors
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Using multivariate binary logistic regression analysis, a significant relation was found between age and
gender of the patients with GOS at 1 month. In our data, female gender (P value: 0.019) and greater
age of patients (P value: 0.018) was associated with worse outcome in VAI (odds ratio 0.212 and
1.039). Using logistic regression, we found no association between age/gender/GCS at
presentation/primary or secondary EVD and length of hospital stay (P value: >0.05). There was a
significant association between diagnosis and length of hospital stay. However, our patient numbers
were not large enough to establish which conditions were associated with longer hospital stay.
DISCUSSION
The patients included in our study were selected after strict evaluation of their previous CSF sterility
status. Strict inclusion criteria limited the sample size to 256 from the original 369 cases identified. Of
these 256 subjects, 66 contracted EVD-related infection, so the incidence of infection was found to be
25.8%. This was a little higher compared to various other published studies conducted in similar
tertiary care hospitals.[3,13] Some studies have reported significantly lower incidence rates of
infection, the probable cause of these low rates is due to varying definitions of EVD infection and
different inclusion and exclusion criteria.[5] Such differences in basic definition of infection lead to
over or under estimation of similarly evaluated data.
Our study focused mainly on the mortality associated with EVD infection. It was seen that the
mortality rate was significantly high at 15.1%. This included all the patients who did not survive after
they were diagnosed with infection. Cause of mortality or differences in management protocols were
however not considered. The data available on mortality associated with EVD infection is extremely
limited. However, in our study, no significant correlation was found between patient demographics and
mortality associated with EVD infection.
It was seen that the mean number of EVD days for patients who developed infection was 19.61 days in
contrast to the patients who did not develop infection who had EVD for a mean of 7.09 days. This
difference is significant and leads to a conclusion that the longer the duration of EVD the higher the
rate of infection. These findings were consistent with another study done which showed that people
who developed infection had EVD in place for twice as many days as those who did not develop
infection with EVD.[8,9] Conversely, another study by Hagel et al. highlighted that the reason for
prolongation of EVD is the development of infection and not vice versa.[5]
In the process of infection detection, the main tools used were Cerebro-Spinal Fluid Culture &
Sensitivity (CSFCS), Cerebro-Spinal Fluid Detailed Report (CSFDR), and EVD tip culture. It was seen
that 95.4% patients had positive CSFCS and CSFDR. EVD tip cultures were positive only in 4.5% of
the cases indicating low sensitivity for this form of diagnosis. EVD tip culture is hence a very poor
diagnostic method, and in most cases, was thought to be contaminated during the removal process and
therefore did not give a true representation of the CSF. When identifying the causative agents in our
study we identified that 51.5% of the subjects were infected with gram-negative organisms and the
remaining 43.9% were infected with gram-positive organisms. In our data, the most commonly isolated
organism was coagulase-positive staph. The main reason for this high staph count was the introduction
of skin flora in the CSF after skin breakdown during the shunt insertion process. Skin flora has been
found as main culprit behind EVD infection.[17]
We identified that gram-negative bacteria were associated with a higher mortality. Of all the
nonsurvivors in our study, 63.6% were the ones infected by gram-negative bacteria. This link has been
studied in the past with an established association of gram-negative infection with higher rates
mortality in patients with nosocomial meningitis.[16]
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It was identified that out of the gram-negative isolates, Acinetobacter was the most commonly isolated
organism.[11,15] It was also the main organism responsible for significant mortality with 27.2% of all
deaths associated with Acinetobacter.[7] This has been studied in the past where similar results have
been obtained with Acinetobacter mortality being higher in most cases with mean ranging from 15% to
71%.[7]
There are several limitations to this study. The retrospective nature of data collection limits accurate
data analysis. The indications for the placement of EVD were heterogenous. Due to relatively small
sample sub group analysis could not be carried out separately for different diagnosis. Despite these
limitations, we believe that the results of the study provide information of clinical significance.
CONCLUSION
We found a high incidence of VAI at out center. It is significantly associated with increased morbidity,
mortality, prolonged hospital stay, and poor outcome. Gram-positive organisms were the most frequent
pathogen whereas gram-negative infection particularly Acinetobacter is associated with higher
mortality.
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